000906390 001__ 906390
000906390 005__ 20230123110601.0
000906390 0247_ $$2doi$$a10.1159/000521626
000906390 0247_ $$2ISSN$$a1660-8151
000906390 0247_ $$2ISSN$$a2235-3186
000906390 0247_ $$2Handle$$a2128/31565
000906390 0247_ $$2pmid$$a35093948
000906390 0247_ $$2WOS$$aWOS:000750626400001
000906390 037__ $$aFZJ-2022-01412
000906390 082__ $$a610
000906390 1001_ $$0P:(DE-HGF)0$$aEtges, Annika$$b0
000906390 245__ $$aA Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life
000906390 260__ $$aBasel$$bKarger$$c2022
000906390 3367_ $$2DRIVER$$aarticle
000906390 3367_ $$2DataCite$$aOutput Types/Journal article
000906390 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1658903496_11504
000906390 3367_ $$2BibTeX$$aARTICLE
000906390 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000906390 3367_ $$00$$2EndNote$$aJournal Article
000906390 500__ $$aFunding: This study was funded by the Ministerium für Kultur und Wissenschaftder Landes Nordrhein-Westfalen (Rückkehrprogramm),the Stiftung Charité (BIH_PRO_406), and the German ResearchFoundation (DFG, SCHO 1386/2-1; project-ID 431984000, CRC1453), all to U.I.S. It was funded by the Deutsche Forschungsgemeinschaft(German Research Foundation) to J.P.M. (MA 7525/2-1, as part of the research unit FOR 5046, project P2) and by a grantfrom the Interdisciplinary Centre for Clinical Research within thefaculty of Medicine at the RWTH Aachen University (IZKF TN1-3/IA532003). The authors gratefully acknowledge the computingtime granted through JARA on the supercomputer JURECA atForschungszentrum Jülich. Funding agencies had no role in thepreparation of the manuscript.
000906390 520__ $$aIntroduction: Pseudohypoaldosteronism type II (PHA II) is a Mendelian disorder, featuring hyperkalemic acidosis and low plasma renin levels, typically associated with hypertension. Mutations in WNK1, WNK4, CUL3, and KLHL3 cause PHA II, with dominant mutations in WNK1, WNK4, and CUL3 and either dominant or recessive mutations in KLHL3. Fourteen families with recessive KLHL3 mutations have been reported, with diagnosis at the age of 3 months to 56 years, typically in individuals with normal kidney function. Methods: We performed clinical and genetic investigations in a patient with hyperkalemic hypertension and used molecular dynamics simulations, heterologous expression in COS7 cells, and Western blotting to investigate the effect of a KLHL3 candidate disease mutation on WNK4 protein expression. Results: The patient, a 58-year-old woman from a consanguineous family, showed hypertension, persistent hyperkalemic acidosis associated with severe muscle pain, nephrolithiasis, chronic kidney disease (CKD), and coronary heart disease. Therapy with hydrochlorothiazide corrected hyperkalemia, hypertension, and muscle pain. Genetic analysis revealed a homozygous p.Arg431Trp mutation at a highly conserved KLHL3 position. Simulations suggested reduced stability of the mutant protein, which was confirmed by Western blot. Compared with wild-type KLHL3, cotransfection of p.Arg431Trp KLHL3 led to increased WNK4 protein levels, inferred to cause increased NaCl reabsorption via the thiazide-sensitive carrier and PHA II. Conclusions: Even in patients presenting late in life and in the presence of CKD, PHA II should be suspected if renin levels are low and hyperkalemic acidosis and hypertension are inadequate for CKD stage, particularly in the presence of a suspicious family history
000906390 536__ $$0G:(DE-HGF)POF4-5241$$a5241 - Molecular Information Processing in Cellular Systems (POF4-524)$$cPOF4-524$$fPOF IV$$x0
000906390 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000906390 7001_ $$0P:(DE-HGF)0$$aHellmig, Nicole$$b1
000906390 7001_ $$0P:(DE-HGF)0$$aWalenda, Gudrun$$b2
000906390 7001_ $$0P:(DE-Juel1)189098$$aHaddad, Bassam G.$$b3$$ufzj
000906390 7001_ $$0P:(DE-Juel1)156429$$aMachtens, Jan-Philipp$$b4
000906390 7001_ $$0P:(DE-HGF)0$$aMorosan, Thomas$$b5
000906390 7001_ $$0P:(DE-HGF)0$$aRump, Lars Christian$$b6
000906390 7001_ $$00000-0002-0309-8045$$aScholl, Ute I.$$b7$$eCorresponding author
000906390 773__ $$0PERI:(DE-600)2810853-X$$a10.1159/000521626$$gp. 1 - 11$$n4$$p418-428$$tNephron$$v146$$x1660-8151$$y2022
000906390 8564_ $$uhttps://juser.fz-juelich.de/record/906390/files/521626.pdf$$yOpenAccess
000906390 909CO $$ooai:juser.fz-juelich.de:906390$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000906390 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)189098$$aForschungszentrum Jülich$$b3$$kFZJ
000906390 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156429$$aForschungszentrum Jülich$$b4$$kFZJ
000906390 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5241$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
000906390 9141_ $$y2022
000906390 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000906390 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000906390 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000906390 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000906390 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000906390 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-10$$wger
000906390 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-10
000906390 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-10
000906390 920__ $$lyes
000906390 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x0
000906390 980__ $$ajournal
000906390 980__ $$aVDB
000906390 980__ $$aUNRESTRICTED
000906390 980__ $$aI:(DE-Juel1)IBI-1-20200312
000906390 9801_ $$aFullTexts